Fiduciary Trust’s Dynavax Technologies DVAX Stock Holding History

Fiduciary Trust’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,840	Closed	-$197K	–	879
2025 Q4	$197K	Buy	12,840 +104	+0.8%	+$1.15K	﹤0.01%	845
2025 Q3	$126K	Buy	+12,736	New	+$133K	﹤0.01%	839

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fiduciary Trust's DVAX Position: Q1 2026 in Review

Fiduciary Trust sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 12,840 shares — an estimated $197K sold.

Fiduciary Trust first reported a position in DVAX in Q3 2025 and held it in 2 quarters. The position peaked at $197K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Fiduciary Trust reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Fiduciary Trust sold 12,840 Dynavax Technologies shares in Q1 2026, an estimated $197K.
Fiduciary Trust first reported a position in Dynavax Technologies in Q3 2025 and held it in 2 quarters.
Fiduciary Trust's Dynavax Technologies position peaked at $197K in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.